Study of optimization pathways for diagnostic processes in patients treated for primary lung cancer, through multi-source process analysis
Longitudinal follow-up of patients with inoperable stage III non-small cell lung cancer treated with durvalumab, via the National Cancer Institute’s Cancer Data Platform
Longitudinal Follow-Up of Patients with Advanced Non-Small-Cell Lung Cancer Treated with Sotorasib Through an Early Access Program
Description of the care pathways for patients with advanced or metastatic non-small-cell lung cancer with an EGFR mutation.
